Tradestie Institutional Equity Comparison Engine
OABI vs CGEN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CGEN Overall Edge
CGEN Captures Institutional Edge (2โ2 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Compugen Ltd (CGEN) driven by superior Valuation, Growth & Margin while OABI counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, OABI trades at N/M Forward P/E with -92.9% operating margin (+78.3% YoY revenue) versus CGEN at 12.4x Forward P/E and 41.3% operating margin (+102.1% YoY). In options structure, OABI sits in SURGE (20th %ile IV; Dealer Gamma Walls on Pro) against CGEN sits in BREAKDOWN (57th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CGEN
OABI N/M vs CGEN 12.4x Fwd P/E
Growth & Margin Winner
CGEN
Op Margin -92.9% vs 41.3% ยท YoY +78.3% vs +102.1%
Momentum & Technical Winner
OABI
1Y +223.7% vs +23.2% ยท 52W Pos 90% vs 33%
Options & Structure Winner
OABI
SURGE (20th %ile IV) vs BREAKDOWN (57th %ile IV)
OABI
NASDAQ
OmniAb, Inc. Common Stock
Services-Commercial Physical & Biological Research
$5.05
+3.27% 1D
Market Cap
$713.3M
1M Return
+7.68%
1Y Return
+223.72%
Forward P/E
N/M
Unified AI Score
56.2 / 100
HOLD
Tech 50.0
Fund 51.0
Flow 54.0
Mom 50.0
CGEN
NASDAQ
Compugen Ltd
Biological Products, (No Diagnostic Substances)
$2.02
-0.98% 1D
Market Cap
$193.2M
1M Return
+2.54%
1Y Return
+23.17%
Forward P/E
12.4x
Unified AI Score
49.8 / 100
HOLD
Tech 53.0
Fund 52.0
Flow 55.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OABI +223.72%
CGEN +23.17%
Spread: +200.55 pp (OABI Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OABI Revenue | CGEN Revenue | OABI Op. Margin | CGEN Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2016 | N/A | $0M | N/A | -4576.3% | CGEN |
| FY2018 | N/A | $20M | N/A | -130.5% | CGEN |
| FY2020 | N/A | $0M | N/A | -1574.8% | CGEN |
| FY2021 | $30M | $10M | -102.5% | -584.6% | OABI |
| FY2022 | $60M | $10M | -45.1% | -471.7% | OABI |
| FY2023 | $30M | $30M | -203.2% | -38.8% | CGEN |
| FY2024 | $30M | $30M | -282.3% | -53.4% | CGEN |
| FY2025 | $20M | $70M | -369.5% | 43.1% | CGEN |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OABI | CGEN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $713.3M | $193.2M | Larger Scale | OABI |
| Trailing P/E Ratio Valuation | N/M | 5.2x | Lower Multiple | CGEN |
| Forward P/E Ratio Valuation | N/M | 12.4x | Lower Multiple | CGEN |
| Revenue Growth (YoY) Growth | +78.3% | +102.1% | Higher Growth | CGEN |
| Operating Margin (TTM) Profitability | -92.9% | 41.3% | Higher Margin | CGEN |
| Net Profit Margin Profitability | -108.1% | 47.9% | Higher Margin | CGEN |
| Return on Equity (ROE) Capital Efficiency | -16.5% | 57.2% | Higher ROE | CGEN |
| 52-Week Range Position Momentum | 90% ($1โ$5) | 33% ($1โ$3) | Stronger Trend | OABI |
| Beta / 30D Volatility Risk Regime | 1.23ฮฒ ยท 57% Vol | 1.44ฮฒ ยท 62% Vol | Lower Realized Risk | OABI |
| Unified Institutional Score Composite Signal | 56.2 / 100 (HOLD) | 49.8 / 100 (HOLD) | Higher Composite | OABI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OABI vs CGEN Buy Guide
OABI
SURGE
14d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
20th %ile
IV Regime
Compressed (<25th %ile)
CGEN
BREAKDOWN
143d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
57th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OABI nor CGEN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.